Mark Maurer

The U.K. drugmaker recently direct-listed its shares in the U.S., betting on a new-drug pipeline to achieve its revenue target by 2030.

The school year is ending, but for accounting professors, the challenge of shaking up a traditionally static curriculum is just beginning.

The school year is ending, but for accounting professors, the challenge of shaking up a traditionally static curriculum is just beginning.

Christina Ho, a dissenting voice on the PCAOB in recent years, serves as Oath’s chief assurance officer

Finance chiefs are trying to get a better read on how much AI their companies are using to avoid a sticker shock moment as vendors begin charging for the technology by tokens.

Read this exciting story from The Wall Street Journal June 06, 2026 issue. Finance chiefs are trying to get a better read on how much their companies are using to avoid a sticker shock moment as vendors begin charging for the technology by tokens.

As AI threatens to make the billable hour obsolete, professional-services firms wrestle with reinventing how they charge clients.

Investors’ artificial-intelligence worries weigh on efforts to exit software holdings.

The private-equity industry's next decade could be a slog. Buyout firms face a backlog of unsold portfolio companies that is only worsening as

Lauren Thomas, Mark Maurer Private-equity firm Warburg Pincus is near a deal to buy specialty-pharmacy company PANTHERx Rare for over $7 billion, including debt, according to people familiar with the matter.